ARTICLE | Company News
Actelion cardiovascular news
January 27, 2014 8:00 AM UTC
The U.S. Department of Justice dismissed a qui tam case against Actelion related to its pulmonary arterial hypertension (PAH) drug Tracleer bosentan. In 2010, Actelion's Actelion Pharmaceuticals U.S....